# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-19-055094
Filing Date
2019-10-21
Accepted
2019-10-21 08:05:47
Documents
20
Period of Report
2019-10-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm1920614d1_8k.htm | 8-K | 20424
2 | EXHIBIT 99.1 | tm1920614d1_ex99-1.htm | EX-99.1 | 10605
3 | EXHIBIT 99.2 | tm1920614d1_ex99-2.htm | EX-99.2 | 4694
4 | EXHIBIT 99.3 | tm1920614d1_ex99-3.htm | EX-99.3 | 4281
5 | EXHIBIT 99.4 | tm1920614d1_ex99-4.htm | EX-99.4 | 4499
6 | GRAPHIC | ex99x1_001.jpg | GRAPHIC | 76110
7 | GRAPHIC | ex99x1_002.jpg | GRAPHIC | 75060
8 | GRAPHIC | ex99x1_003.jpg | GRAPHIC | 86038
9 | GRAPHIC | ex99x1_004.jpg | GRAPHIC | 77422
10 | GRAPHIC | ex99x1_005.jpg | GRAPHIC | 43006
11 | GRAPHIC | ex99x1_006.jpg | GRAPHIC | 56662
12 | GRAPHIC | ex99x1_007.jpg | GRAPHIC | 61349
13 | GRAPHIC | ex99x1_008.jpg | GRAPHIC | 62735
14 | GRAPHIC | ex99x1_009.jpg | GRAPHIC | 60297
15 | GRAPHIC | ex99x1_010.jpg | GRAPHIC | 68320
16 | GRAPHIC | ex99x1_011.jpg | GRAPHIC | 51167
17 | GRAPHIC | ex99x2_001.jpg | GRAPHIC | 140160
18 | GRAPHIC | ex99x3_001.jpg | GRAPHIC | 142983
19 | GRAPHIC | ex99x4_001.jpg | GRAPHIC | 137475
20 | GRAPHIC | image_001.jpg | GRAPHIC | 5687
| Complete submission text file | 0001104659-19-055094.txt |  | 1624157

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 191158795
SIC: 2834 Pharmaceutical Preparations